A 70-year-old patient with normal renal function is started on a medication that is eliminated primarily unchanged by the kidneys. Compared with a healthy 30-year-old adult, which pharmacokinetic change is most likely to contribute to a higher steady-state plasma concentration in the elderly patient at the same weight-based dose?